A SpaceX Dragon spacecraft was scheduled to depart the International Space Station no earlier than Nov. 18, carrying research samples and equipment back to Earth. In a Nov. 17 NASA media advisory by Lauren E. Low, NASA said the timing depended on weather and that teams would adjust the plan as needed.
The returning cargo includes a 3D-bioprinted blood vessel construct used to study vascular aging and cardiovascular disease in space and on Earth. NASA said frozen tumor organoids treated aboard the station would also return; researchers hope they can help identify ways to improve cancer treatments and advance personalized medicine. The advisory describes planned research uses, not results from these samples.
Frozen microbial samples are set to be analyzed to learn more about how antibiotic-resistant bacteria survive, adapt and evolve in space. NASA also said a lighting system would return after more than three years aboard the station, where researchers tested its potential to support astronauts’ sleep and well-being during long-duration missions. The advisory does not report whether that system improved sleep or well-being.
NASA said the Dragon would undock from the Harmony module’s space-facing port at 11:05 a.m. EST, after a command from SpaceX ground controllers in Hawthorne, California. Live coverage of the departure was scheduled to begin at 10:45 a.m. The agency and SpaceX were targeting a splashdown off California no earlier than 1:50 a.m. on Nov. 19, subject to conditions in the recovery area; NASA said it would post updates but not stream the splashdown.
The spacecraft arrived at the station on Oct. 15 with more than 6,300 pounds of crew supplies, science investigations and equipment. NASA said thousands of pounds of cargo were returning. The agency described the research as potentially useful for future space exploration and life on Earth, while the samples’ eventual findings remain to be established.